These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 31051151)
1. Prognostic Significance of Longitudinal Clinical Congestion Pattern in Chronic Heart Failure: Insights From TIME-CHF Trial. Simonavičius J; Sanders van-Wijk S; Rickenbacher P; Maeder MT; Pfister O; Kaufmann BA; Pfisterer M; Čelutkienė J; Puronaitė R; Knackstedt C; van Empel V; Brunner-La Rocca HP Am J Med; 2019 Sep; 132(9):e679-e692. PubMed ID: 31051151 [TBL] [Abstract][Full Text] [Related]
2. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). Lala A; McNulty SE; Mentz RJ; Dunlay SM; Vader JM; AbouEzzeddine OF; DeVore AD; Khazanie P; Redfield MM; Goldsmith SR; Bart BA; Anstrom KJ; Felker GM; Hernandez AF; Stevenson LW Circ Heart Fail; 2015 Jul; 8(4):741-8. PubMed ID: 26041600 [TBL] [Abstract][Full Text] [Related]
3. Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF. Simonavičius J; Maeder MT; Eurlings CGMJ; Aizpurua AB; Čelutkienė J; Barysienė J; Toggweiler S; Kaufmann BA; Brunner-La Rocca HP Clin Res Cardiol; 2021 Aug; 110(8):1221-1233. PubMed ID: 33216179 [TBL] [Abstract][Full Text] [Related]
4. The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided Therapy. Mallick A; Gandhi PU; Gaggin HK; Ibrahim N; Januzzi JL JACC Heart Fail; 2016 Sep; 4(9):749-55. PubMed ID: 27179830 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of Antigen Carbohydrate 125 and N-Terminal Pro-B-Type Natriuretic Peptide for Assessing Congestion in Chronic Heart Failure: Insights from the CARDIOREN Registry. Gayán Ordás J; Nuñez J; Bascompte Claret R; Llacer P; Zegri-Reiriz I; de la Espriella R; Fort A; Rubio-Gracia J; Blazquez-Bermejo Z; Mendez A; Ponz I; Rodriguez Chaverri A; Caravaca-Pérez P; Recio Mayoral A; Jiménez Rubio C; Pomares A; José Soler M; Fluviá P; García Magallón B; Luis Górriz J; Manzano L; Husain-Syed F; Cobo Marcos M Cardiorenal Med; 2024; 14(1):543-555. PubMed ID: 39236691 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF. Selvaraj S; Claggett B; Pozzi A; McMurray JJV; Jhund PS; Packer M; Desai AS; Lewis EF; Vaduganathan M; Lefkowitz MP; Rouleau JL; Shi VC; Zile MR; Swedberg K; Solomon SD Circulation; 2019 Oct; 140(17):1369-1379. PubMed ID: 31510768 [TBL] [Abstract][Full Text] [Related]
7. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. Pfisterer M; Buser P; Rickli H; Gutmann M; Erne P; Rickenbacher P; Vuillomenet A; Jeker U; Dubach P; Beer H; Yoon SI; Suter T; Osterhues HH; Schieber MM; Hilti P; Schindler R; Brunner-La Rocca HP; JAMA; 2009 Jan; 301(4):383-92. PubMed ID: 19176440 [TBL] [Abstract][Full Text] [Related]
8. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). Maeder MT; Rickenbacher P; Rickli H; Abbühl H; Gutmann M; Erne P; Vuilliomenet A; Peter M; Pfisterer M; Brunner-La Rocca HP; Eur J Heart Fail; 2013 Oct; 15(10):1148-56. PubMed ID: 23657728 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of the Combination of In-Hospital Poor Diuretic Response and Systemic Congestion to Predict Future Cardiac Events in Patients With Acute Decompensated Heart Failure. Aoki S; Okumura T; Sawamura A; Kitagawa K; Morimoto R; Sakakibara M; Murohara T Am J Cardiol; 2017 Jun; 119(12):2010-2016. PubMed ID: 28438307 [TBL] [Abstract][Full Text] [Related]
10. Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network). Ambrosy AP; Bhatt AS; Gallup D; Anstrom KJ; Butler J; DeVore AD; Felker GM; Fudim M; Greene SJ; Hernandez AF; Kelly JP; Samsky MD; Mentz RJ Am J Cardiol; 2017 Jul; 120(1):98-105. PubMed ID: 28479167 [TBL] [Abstract][Full Text] [Related]
11. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981 [TBL] [Abstract][Full Text] [Related]
12. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [TBL] [Abstract][Full Text] [Related]
13. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF. Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP; Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403 [TBL] [Abstract][Full Text] [Related]
14. The prognostic combined role of B-type natriuretic peptide, blood urea nitrogen and congestion signs persistence in patients with acute heart failure. Ruocco G; Pellegrini M; De Gori C; Franci B; Nuti R; Palazzuoli A J Cardiovasc Med (Hagerstown); 2016 Nov; 17(11):818-27. PubMed ID: 26702597 [TBL] [Abstract][Full Text] [Related]
15. Loop Diuretic Prescription and Long-Term Outcomes in Heart Failure: Association Modification by Congestion. Faselis C; Lam PH; Patel S; Arundel C; Filippatos G; Deedwania P; Zile MR; Wopperer S; Nguyen T; Allman RM; Fonarow GC; Ahmed A Am J Med; 2021 Jun; 134(6):797-804. PubMed ID: 33359271 [TBL] [Abstract][Full Text] [Related]
16. Association of furosemide dose with clinical status, left ventricular dysfunction, natriuretic peptides, and outcome in clinically stable patients with chronic systolic heart failure. Dini FL; Guglin M; Simioniuc A; Donati F; Fontanive P; Pieroni A; Orsini E; Caravelli P; Marzilli M Congest Heart Fail; 2012; 18(2):98-106. PubMed ID: 22432556 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of the Severity of Clinical Congestion in Patients Hospitalized for Decompensated Heart Failure: Findings From the Japanese KCHF Registry. Aida K; Nagao K; Kato T; Yaku H; Morimoto T; Inuzuka Y; Tamaki Y; Yamamoto E; Yoshikawa Y; Kitai T; Taniguchi R; Iguchi M; Kato M; Takahashi M; Jinnai T; Kawai T; Komasa A; Nishikawa R; Kawase Y; Morinaga T; Su K; Kawato M; Seko Y; Inada T; Inoko M; Toyofuku M; Furukawa Y; Nakagawa Y; Ando K; Kadota K; Shizuta S; Ono K; Sato Y; Kuwahara K; Ozasa N; Kimura T J Card Fail; 2023 Aug; 29(8):1150-1162. PubMed ID: 36690136 [TBL] [Abstract][Full Text] [Related]